Stocks

The latest stocks coverage from the TrustFinance editorial desk.

Latest in Stocks
Immix Biopharma Stock Plummets After Report Reveals CMO Was a Fugitive

Stocks

Immix Biopharma Stock Plummets After Report Reveals CMO Was a Fugitive

Jul 20, 2026

Shares of Immix Biopharma plunged after an investigative report from STAT News revealed the company's recently hired Chief Medical Officer was a fugitive who had been evading law enforcement for nearly two decades. The disclosure has raised significant questions about the firm's executive vetting process ahead of a key clinical trial readout.